← Back to Search

Keloid Revision Surgery with Biovance for Keloid Scars

Phase 4
Waitlist Available
Led By Dinakar Golla, MD
Research Sponsored by Golla Center for Plastic Surgery
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year post-surgery
Awards & highlights

Study Summary

The main purpose of this study is to see if there is clinical benefit of using Biovance in reduction of the recurrence of keloids when used to revise them. It will also assess the postoperative complications.

Eligible Conditions
  • Keloid Scars

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year post-surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year post-surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Incidence of keloid scar recurrence after revision surgery with placement of Biovance
Secondary outcome measures
Clinical outcomes of keloid scar revision surgery, including scar size and appearance
Incidence of complications (including infection, incision dehiscence, hematoma, seroma, and wound necrosis following revision surgery

Trial Design

1Treatment groups
Experimental Treatment
Group I: Keloid Revision Surgery with BiovanceExperimental Treatment1 Intervention
All enrolled patients will have Biovance applied during Keloid Revision Surgery

Find a Location

Who is running the clinical trial?

Golla Center for Plastic SurgeryLead Sponsor
Dinakar Golla, MDPrincipal InvestigatorGolla Center for Plastic Surgery

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What site did they apply to?
Golla Center for Plastic Surgery
What portion of applicants met pre-screening criteria?
Met criteria

Why did patients apply to this trial?

I've tried other treatments that barely work or they go away and come back.
PatientReceived 1 prior treatment
Recent research and studies
Journal of Investigative DermatologyJournal
Genome Scans Provide Evidence for Keloid Susceptibility Loci on Chromosomes 2q23 and 7p11
Marneros, Alexander G., James E.C. Norris, Shoji Watanabe, Ernst Reichenberger, and Bjorn R. Olsen. 2004. “Genome Scans Provide Evidence for Keloid Susceptibility Loci on Chromosomes 2q23 and 7p11”. Journal of Investigative Dermatology. Elsevier BV. doi:10.1111/j.0022-202x.2004.22327.x.
clinicaltrials.govStudy
Pilot Study to Evaluate Clinical Outcomes With the Use of Biovance Following Keloid Scar Revision Surgery
2015. "Pilot Study to Evaluate Clinical Outcomes With the Use of Biovance Following Keloid Scar Revision Surgery". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02521402.
All > Scar
~1 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top